Meredith Blake
by Mark Blake
Supporters
Thank you for contributing in honor of Meredith Blake, who passed away from low grade serous ovarian cancer at the age of 52 just over 3 years past diagnosis. Here is her own statement she wrote for all of us:
If you’re reading this, I am gone. Though I didn’t post on IG a lot, it was my only form of communication with some people so I asked Mark to post this for me just so there would be some closure.
I’m not going to beat you over the head with some life lesson gleaned while being in the realm of the sick. So I’ll keep it simple. I loved life! Even on my darkest days I felt incredibly lucky and never lost sight of everything I got to experience in the time I had. When I look back over my life, it makes me smile...and that’s all we want in the end, isn’t it?
Most importantly, I spent my remaining time hunkered down with the people I love most in the world; my husband Mark, my children, my parents, a few of my closest friends and, of course, my Mooch & Mosey. We were able to reminisce about the past, talk openly about the future and just generally enjoy our time together. That time alone was a truly incredible gift! So please, do not say “she lost her battle”. As far as I’m concerned, I won.
Sending my love to you all from the other side- wherever that might be!
If you are in a giving mood, please consider giving to STAAROC , THE ONLY U.S. FOUNDATION DEDICATED TO FUNDING LGSOC RESEARCH.
STAAR exists to fund life-saving research for women with low-grade serous, a rare and severely underfunded ovarian cancer subtype. Low-grade serous represents fewer than 8% of cases of ovarian cancer and disproportionately affects younger women. Further, being a rare cancer means that private donations are critical to fund research. More research means more time for adventures, more holidays, and more memory making!
Thank you for your support and interest in being part of our fundraising efforts. Join our mailing list and follow us on Facebook and Instagram to keep up with the latest in research and on the studies we fund from the fundraising YOU supported.